Lactate Dehydrogenase B and Pyruvate Oxidation Pathway Associated With Carfilzomib-Related Cardiotoxicity in Multiple Myeloma Patients: Result of a Multi-Omics Integrative Analysis

Multiple myeloma (MM) is the second most frequent hematologic cancer in the United States. Carfilzomib (CFZ), an irreversible proteasome inhibitor being used to treat relapsed and refractory MM, has been associated with cardiotoxicity, including heart failure. We hypothesized that a multi-omics appr...

Descripción completa

Detalles Bibliográficos
Autores principales: Tantawy, Marwa, Chekka, Lakshmi Manasa, Huang, Yimei, Garrett, Timothy J., Singh, Sonal, Shah, Chintan P., Cornell, Robert F., Baz, Rachid C., Fradley, Michael G., Waheed, Nida, DeRemer, David L., Yuan, Lihui, Langaee, Taimour, March, Keith, Pepine, Carl J., Moreb, Jan S., Gong, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116486/
https://www.ncbi.nlm.nih.gov/pubmed/33996940
http://dx.doi.org/10.3389/fcvm.2021.645122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116486/
https://www.ncbi.nlm.nih.gov/pubmed/33996940
http://dx.doi.org/10.3389/fcvm.2021.645122

Ejemplares similares